gvtcx

NHS Type 2 Diabetes Path to Remission Programme Wave 4 (previously LCD)

Procurement Manager Published 16 Feb 2024 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£4,941,420
Statuscomplete
Category (CPV) 85100000
Deadline24 Aug 2023
Contract start1 Apr 2024
Contract end31 Mar 2027
Procedureselective
SME suitableYes
OCIDocds-b5fd17-62f611db-9320-4640-b435-9bedfe5b1bb8

Awards (4)

This procurement was awarded to 4 suppliers. Values shown are per-award; the notice total is £4,941,420.

SupplierValueDateStatus
Counterweight shared £4,941,420 5 Feb 2024 active
Momenta Newcastle Ltd shared £4,941,420 5 Feb 2024 active
Oviva UK Limited shared £4,941,420 5 Feb 2024 active
Pulse Healthcare Limited shared £4,941,420 5 Feb 2024 active

description

NHS Type 2 Diabetes Path to Remission Programme Wave 4 Further competition for 11 ICSs

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
16 Feb 2024 Award (award) · 03f104ad-f071-46dd-b98c-6ee70043c1ff-724350

more from Procurement Manager

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.